Chronic Inflammatory Demyelinating Polyneuropathy Market Analysis, Epidemiology and Market Forecast to 2030
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare neurological disorder characterized by progressive weakness and impaired sensory function in the legs and arms mainly caused by damage to the myelin sheath (the fatty covering that wraps around and protects nerve fibres) of the peripheral nerves.
Key Highlight of Chronic Inflammatory Demyelinating Polyneuropathy Market
In 2017, prevalent cases of typical and atypical CIDP in the US varied as 10,342 and 9,936, respectively.
According to DelveInsight estimates, the total prevalent population of CIDP in 7MM was found to be 44,843 in 2017.Â
Among the 7MM countries, the United States has a higher population of CIDP.
According to DelveInsight’s analysis, Males are at more at risk to develop CIDP than Females
For more detais on Chronic Inflammatory Demyelinating PolyneuropathyÂ
Market visit:
https://www.delveinsight.com/report-store/chronic-inflammatory-demyelinating-polyneuropathy-cidp-market
